Oral vaccination with the porcine circovirus type 2 (PCV-2) capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice.
L WangD ZhaoB SunM YuY WangY RuY JiangX QiaoW CuiH ZhouY LiYigang XuL TangPublished in: Journal of applied microbiology (2019)
This study demonstrates the potential of the genetically engineered Lactococcus lactis as a candidate for an oral vaccine against PCV2.